NANJING, China, Feb. 24, 2026 /PRNewswire/ -- Frontier Biotechnologies Inc. (hereinafter referred to as "Frontier Biotech" or "the Company") has entered into an exclusive licensing agreement with GSK, a global biopharma company. Under the terms of the agreement, GSK will obtain exclusive...
Hence then, the article about frontier biotech and gsk enter global exclusive licensing agreement for small interfering rna therapeutics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Frontier Biotech and GSK Enter Global Exclusive Licensing Agreement for Small Interfering RNA Therapeutics )
Also on site :
- Certis and FieldAI Form Strategic Partnership to Deploy Autonomous Robotics in Real-World Security Operations
- Peter Mandelson arrest latest: Peer released on bail as Epstein accuser Virginia Giuffre’s family issues statement
- Discord cuts ties with Peter Thiel-backed verification software after its code was found tied to U.S. surveillance efforts